(Total Views: 349)
Posted On: 05/16/2018 8:32:42 AM
Post# of 11803
Re: weaver_525 #4921
Regarding the Suit:
"We believe that our 2016 suit against J&J will be settled sooner rather than later. Nonetheless, the company is prepared to litigate this case to its conclusion, and if necessary bring into the suit the acquirer of J&J’s
diabetes divisions. Further, in January 2016 the US Supreme Court ruled that the Doctrine of Laches, a defense used by many Defendants in patent infringement suits could no longer be used. This ruling further deprived J&J of
one of its most important (time wasting) defenses against the company’s current patent infringement claims."
"We believe that our 2016 suit against J&J will be settled sooner rather than later. Nonetheless, the company is prepared to litigate this case to its conclusion, and if necessary bring into the suit the acquirer of J&J’s
diabetes divisions. Further, in January 2016 the US Supreme Court ruled that the Doctrine of Laches, a defense used by many Defendants in patent infringement suits could no longer be used. This ruling further deprived J&J of
one of its most important (time wasting) defenses against the company’s current patent infringement claims."
(0)
(0)
